Clinical Trial Update: Evaluation of RTVue XR With SSADA

View source ↗

Summary

A clinical trial evaluating the RTVue XR with SSADA for retinal vascular pathology has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinal Vascular Disease

Drugs mentioned

• RTVue XR with SSADA

Snippet

Sponsor: Optovue | Conditions: Retina Vascular Pathology | Status: COMPLETED